Lineage Cell Therapeutics (LCTX) Cash from Investing Activities (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.83% |
| Dec 31, 2025 | -127,683.33% |
| Sep 30, 2025 | 14.29% |
| Jun 30, 2025 | -100.74% |
| Mar 31, 2025 | -27.78% |
| Dec 31, 2024 | -32.23% |
| Sep 30, 2024 | 144.22% |
| Jun 30, 2024 | -23,039.47% |
| Mar 31, 2024 | -100.39% |
| Dec 31, 2023 | 359.10% |
| Sep 30, 2023 | -88.92% |
| Jun 30, 2023 | 24.20% |
| Mar 31, 2023 | 402.35% |
| Dec 31, 2022 | 87.53% |
| Sep 30, 2022 | -42,079.38% |
| Jun 30, 2022 | -110.87% |
| Mar 31, 2022 | 68.49% |
| Dec 31, 2021 | -114.71% |
| Sep 30, 2021 | 40.87% |
| Jun 30, 2021 | -101.14% |